Literature DB >> 9237046

Neurovascular [125I]-ET-1 binding sites on human peripheral nerve.

M R Dashwood1, P K Thomas.   

Abstract

[125I]-ET-1 binding to human peripheral nerve was studied using a combination of in vitro autoradiography and immunohistochemistry. Dense binding was predominantly to ETA receptors located on smooth muscles cells of the neural microvessels and the perineurium. These results identify regions where locally-released ET-1 may affect neural vascular perfusion and play a pathophysiological role in certain conditions, such as diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237046     DOI: 10.3109/10623329709079870

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  5 in total

1.  Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception.

Authors:  J D Pomonis; S D Rogers; C M Peters; J R Ghilardi; P W Mantyh
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia.

Authors:  Michael Richard Dashwood; Janice C S Tsui
Journal:  J Cell Commun Signal       Date:  2010-11-27       Impact factor: 5.782

3.  Endothelin-1 and endothelin receptors in the basilar artery of the capybara.

Authors:  Andrzej Loesch; Barbara Gajkowska; Michael R Dashwood; Emerson T Fioretto; Karina M Gagliardo; Ana R De Lima; Antonio A C M Ribeiro
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

4.  Local antinociception induced by endothelin-1 in the hairy skin of the rat's back.

Authors:  Saurav Shrestha; Neilia G Gracias; Florence Mujenda; Alla Khodorova; Michael R Vasko; Gary R Strichartz
Journal:  J Pain       Date:  2009-07       Impact factor: 5.820

5.  Endothelin-1 as a neuropeptide: neurotransmitter or neurovascular effects?

Authors:  Michael R Dashwood; Andrzej Loesch
Journal:  J Cell Commun Signal       Date:  2009-10-22       Impact factor: 5.782

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.